版本:
中国

BRIEF-Ganaxolone IV clinical data presented at leading international status Epilepticus Medical Conference

April 10 Marinus Pharmaceuticals Inc

* Ganaxolone IV clinical data presented at leading international status Epilepticus Medical Conference

* Marinus Pharma - Results showed every dose regimen of Ganaxolone IV given was generally safe,well-tolerated, reached targeted dose levels in shortperiod of time Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐